Skip to content

NIH’s $36 Billion Dilemma: Long Covid and ME/CFS Research Overlap

The National Institutes of Health (NIH) faces a pivotal moment with its RECOVER Initiative, aimed at addressing long Covid. Critics argue that the initiative has not prioritized patient needs or advanced clinical trials effectively. There’s a growing call from Congress, scientists, and advocates to include myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in the research framework due to its similarities with long Covid. Both conditions share symptoms like post-exertional malaise, cognitive dysfunction, and immune dysregulation. A 2021 study estimates ME/CFS costs the U.S. economy between $36 billion to $51 billion annually in lost productivity and healthcare expenses. Long Covid has further increased this financial burden, affecting an estimated 6.4% of U.S. adults. Despite clear directives from Congress to expand RECOVER’s scope, NIH has sent mixed messages about including ME/CFS, citing limited resources. Integrating ME/CFS could accelerate research into shared biological mechanisms, potentially benefiting millions.

Source: www.statnews.com

Related Links

Related Videos